Recursion Pharmaceuticals, Inc. RXRX Common stock, par value (in dollars per share)
Common stock, par value (in dollars per share) at other companies
Other financials
Where this comes from
Reported directly by Recursion Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CommonStockParOrStatedValuePerShare.
The official record: Recursion Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Recursion Pharmaceuticals, Inc.'s common stock, par value (in dollars per share).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Recursion Pharmaceuticals, Inc.'s common stock, par value (in dollars per share)?
- Recursion Pharmaceuticals, Inc. (RXRX) reported common stock, par value (in dollars per share) of $0 in Q1 2026.
- How has Recursion Pharmaceuticals, Inc.'s common stock, par value (in dollars per share) changed year-over-year?
- Recursion Pharmaceuticals, Inc.'s common stock, par value (in dollars per share) decreased by 0.0% year-over-year, from $0 to $0.
- What is the long-term trend for Recursion Pharmaceuticals, Inc.'s common stock, par value (in dollars per share)?
- Over 5 years (2020 to 2025), Recursion Pharmaceuticals, Inc.'s common stock, par value (in dollars per share) has grown at a 0.0% compound annual growth rate (CAGR), from $0 to $0.